AMDA aims for 25 percent meds reduction in data-sharing deprescribing campaign
By
Alicia Lasek
May 06, 2021
AMDA is challenging industry clinicians and operators to join a push to reduce polypharmacy. Prescribing data will be collected and overall trends analyzed and shared with participants.
‘Already skeptical’ nursing home workers may need persuading after J&J shots resume, industry leaders...
By
Danielle Brown
Apr 26, 2021
Now that vaccinators are encouraged to resume giving Johnson & Johnson’s COVID-19 shot, nursing home stakeholders are questioning what effect the recent pause will have on vaccine uptake in a wary population.
LTC vaccinators opt to briefly halt J&J shots while awaiting FDA guidance
By
Alicia Lasek
Apr 14, 2021
Long-term care pharmacies and clinicians have temporarily paused their use of Johnson & Johnson’s COVID vaccine following recommendations from health officials. Guidance is needed quickly in order to...